Increase in plasma interleukin-10 following hydrocortisone injection

被引:27
|
作者
Dandona, P [1 ]
Aljada, A
Garg, R
Mohanty, P
机构
[1] SUNY Buffalo, Div Endocrinol, Buffalo, NY 14209 USA
[2] KALEIDA Hlth, Buffalo, NY 14209 USA
来源
关键词
D O I
10.1210/jc.84.3.1141
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In view of the fact that glucocorticoids have an immunosuppressive effect and the fact that interleukin-10 (IL-10) is inhibitory to T helper cell function, we have now investigated the effect of hydrocortisone on plasma IL-10 concentrations. Seven normal subjects were injected with 100 mg hydrocortisone intravenously between 8 and 9:00 a.m. Sequential blood samples were obtained prior to and 1,2,4,8 and 24 h after the injection. Plasma IL-10 concentrations increased significantly and consistently following the injection in all subjects. The peak increase of IL-70 occurred at 4 h and the restoration to baseline by 8 h. The sequential values were (mean+/-SD):, 3.0 +/- 1.3 pg/ml at 2 h, 9 +/- 4.2 pg/ml at 4 h, 3.7 +/- 1.8 pg/ml at 8 h and 3.7 +/- 1.4 pg/ml at 24 h. The magnitude of increase was 436% of the basal at peak effect. This effect of hydrocortisone (and possibly other glucocorticoids) may contribute to the immunosuppressive effect of this drug. IL-10 may also be potentially useful in the assessment of Cushing's Syndrome as a marker of end organ effect of glucocorticoids.
引用
收藏
页码:1141 / 1144
页数:4
相关论文
共 50 条
  • [1] Interleukin-10 and the interleukin-10 receptor
    Moore, KW
    Malefyt, RD
    Coffman, RL
    O'Garra, A
    ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 : 683 - 765
  • [2] Increase of interleukin-6 plasma levels after elective craniotomy: Influence of interleukin-10 and catecholamines
    Heesen, M
    Deinsberger, W
    Dietrich, GV
    Detsch, O
    Boldt, J
    Hempelmann, G
    ACTA NEUROCHIRURGICA, 1996, 138 (01) : 77 - 80
  • [3] Increase of serum interleukin-10 in intractable Graves' disease
    Takeoka, K
    Watanabe, M
    Matsuzuka, F
    Miyauchi, A
    Iwatani, Y
    THYROID, 2004, 14 (03) : 201 - 205
  • [4] INTERLEUKIN-10
    MOORE, KW
    OGARRA, A
    MALEFYT, RD
    VIEIRA, P
    MOSMANN, TR
    ANNUAL REVIEW OF IMMUNOLOGY, 1993, 11 : 165 - 190
  • [5] INTERLEUKIN-10
    ZLOTNIK, A
    MOORE, KW
    CYTOKINE, 1991, 3 (05) : 366 - 371
  • [6] INTERLEUKIN-10
    MALEFYT, RD
    YSSEL, H
    RONCAROLO, MG
    SPITS, H
    DEVRIES, JE
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (03) : 314 - 320
  • [7] Mapping of the interleukin-10/interleukin-10 receptor combining site
    Reineke, U
    Sabat, R
    Volk, HD
    Schneider-Mergener, J
    PROTEIN SCIENCE, 1998, 7 (04) : 951 - 960
  • [8] Interleukin-10 and cellular rejection following cardiac transplantation
    El Gamel, A
    Grant, S
    Yonan, N
    Keevil, B
    Aziz, T
    Deiraniya, AK
    Campbell, C
    Rahman, A
    Haselton, P
    Hutchinson, IV
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 2387 - 2388
  • [9] Calcium entry blockers increase interleukin-10 production in endotoxemia
    Szabo, C
    Hasko, G
    Nemeth, ZH
    Vizi, ES
    SHOCK, 1997, 7 (04): : 304 - 307
  • [10] Serum interleukin-10 in plasma-cell dyscrasias
    Stasi, R
    Brunetti, M
    Bussa, S
    Pagano, A
    AMERICAN JOURNAL OF HEMATOLOGY, 1997, 54 (04) : 335 - 337